US Stock MarketDetailed Quotes

SXTC China SXT Pharmaceuticals

Watchlist
  • 0.3820
  • -0.0040-1.04%
Close Feb 14 16:00 ET
  • 0.3850
  • +0.0030+0.79%
Post 17:55 ET
1.55MMarket Cap-0.11P/E (TTM)

China SXT Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2,287.47%-1.93M
-130.10%-80.76K
120.38%268.29K
-240.92%-1.32M
290.58%934.25K
-87.54%239.19K
555.25%1.92M
293.04K
Net income from continuing operations
47.79%-3.1M
-3.46%-5.93M
-108.72%-5.74M
73.29%-2.75M
-768.38%-10.29M
29.61%1.54M
0.21%1.19M
--1.19M
Operating gains losses
----
----
----
-90.95%509K
--5.63M
----
----
----
Depreciation and amortization
-18.75%203.25K
-21.83%250.16K
-7.36%320.01K
4.09%345.41K
83.42%331.84K
39.77%180.92K
30.45%129.44K
--99.23K
Deferred tax
--0
--0
270.30%328.15K
-89.42%-192.68K
-1,217.13%-101.72K
-31.99%-7.72K
---5.85K
----
Other non cash items
-11.28%362.59K
-30.51%408.69K
-46.86%588.11K
-67.01%1.11M
--3.35M
----
----
----
Change In working capital
-126.96%-381.56K
-25.62%1.42M
218.48%1.9M
-182.52%-1.61M
224.52%1.95M
-356.69%-1.56M
161.43%608.99K
---991.33K
-Change in receivables
-133.98%-321.42K
18.76%945.8K
259.05%796.4K
-404.81%-500.72K
111.07%164.28K
-242.73%-1.48M
379.95%1.04M
---371.23K
-Change in inventory
-153.71%-219.65K
326.19%408.95K
-568.14%-180.8K
-2.74%38.62K
-74.30%39.71K
156.32%154.53K
-171.41%-274.38K
--384.22K
-Change in prepaid assets
241.98%172.53K
-96.65%50.45K
209.03%1.5M
-566.89%-1.38M
-640.34%-206.94K
104.29%38.3K
-272.94%-892.32K
--515.96K
-Change in payables and accrued expense
-747.65%-81.53K
-102.91%-9.62K
941.77%330.01K
-102.08%-39.2K
25,524.51%1.89M
-101.06%-7.42K
143.97%703.13K
---1.6M
-Change in other current liabilities
151.15%38.06K
79.38%-74.41K
-206.90%-360.86K
282.64%337.57K
-279.14%-184.83K
-113.36%-48.75K
--365K
----
-Change in other working capital
-67.73%30.44K
150.61%94.34K
-198.48%-186.4K
-125.22%-62.45K
214.35%247.59K
34.72%-216.52K
-521.26%-331.69K
--78.74K
Cash from discontinued investing activities
Operating cash flow
-2,287.47%-1.93M
-130.10%-80.76K
120.38%268.29K
-240.92%-1.32M
290.58%934.25K
-87.54%239.19K
555.25%1.92M
--293.04K
Investing cash flow
Cash flow from continuing investing activities
314.77%26.42K
73.77%-12.3K
99.19%-46.91K
-5.62%-5.81M
-800.97%-5.5M
41.94%-610.09K
-463.97%-1.05M
-186.31K
Net PPE purchase and sale
90.01%-7.06K
-13.11%-70.68K
32.84%-62.49K
77.12%-93.04K
32.09%-406.66K
41.85%-598.81K
-474.68%-1.03M
---179.18K
Net intangibles purchase and sale
----
----
----
----
--0
46.37%-11.28K
-194.90%-21.03K
---7.13K
Net investment purchase and sale
----
----
----
---8.85M
--0
--0
--0
----
Net other investing changes
-42.64%33.49K
274.69%58.38K
-99.50%15.58K
161.54%3.13M
---5.09M
----
----
----
Cash from discontinued investing activities
Investing cash flow
314.77%26.42K
73.77%-12.3K
99.19%-46.91K
-5.62%-5.81M
-800.97%-5.5M
41.94%-610.09K
-463.97%-1.05M
---186.31K
Financing cash flow
Cash flow from continuing financing activities
-189.22%-2.62M
84.41%2.94M
-87.15%1.6M
310.32%12.41M
-66.55%3.02M
2,977.66%9.04M
-521.47%-314.22K
-50.56K
Net issuance payments of debt
-64.58%1.42M
44.49%4M
2,318.39%2.77M
-101.42%-124.95K
12,568.61%8.8M
122.12%69.49K
-521.47%-314.22K
---50.56K
Net common stock issuance
--0
-29.54%2.19M
--3.12M
--0
--0
--6.49M
--0
----
Proceeds from stock option exercised by employees
--0
--0
---30K
--0
--0
----
----
----
Net other financing activities
-24.09%-4.04M
23.55%-3.26M
-134.00%-4.26M
316.88%12.53M
-332.85%-5.78M
--2.48M
----
----
Cash from discontinued financing activities
Financing cash flow
-189.22%-2.62M
84.41%2.94M
-87.15%1.6M
310.32%12.41M
-66.55%3.02M
2,977.66%9.04M
-521.47%-314.22K
---50.56K
Net cash flow
Beginning cash position
11.55%17.37M
16.55%15.57M
83.33%13.36M
-21.58%7.29M
1,312.65%9.29M
903.15%657.77K
473.21%65.57K
--11.44K
Current changes in cash
-258.89%-4.53M
56.81%2.85M
-65.64%1.82M
443.76%5.29M
-117.74%-1.54M
1,461.76%8.67M
888.39%555.22K
--56.17K
Effect of exchange rate changes
27.10%-765.23K
-366.34%-1.05M
-49.76%394.12K
268.06%784.54K
-1,160.84%-466.81K
-200.13%-37.02K
1,909.94%36.98K
---2.04K
End cash Position
-30.46%12.08M
11.55%17.37M
16.55%15.57M
83.33%13.36M
-21.58%7.29M
1,312.65%9.29M
903.15%657.77K
--65.57K
Free cash flow
-1,177.80%-1.94M
-173.59%-151.44K
114.60%205.8K
-367.18%-1.41M
242.25%527.59K
-142.66%-370.89K
714.58%869.44K
--106.73K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
--
(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2,287.47%-1.93M-130.10%-80.76K120.38%268.29K-240.92%-1.32M290.58%934.25K-87.54%239.19K555.25%1.92M293.04K
Net income from continuing operations 47.79%-3.1M-3.46%-5.93M-108.72%-5.74M73.29%-2.75M-768.38%-10.29M29.61%1.54M0.21%1.19M--1.19M
Operating gains losses -------------90.95%509K--5.63M------------
Depreciation and amortization -18.75%203.25K-21.83%250.16K-7.36%320.01K4.09%345.41K83.42%331.84K39.77%180.92K30.45%129.44K--99.23K
Deferred tax --0--0270.30%328.15K-89.42%-192.68K-1,217.13%-101.72K-31.99%-7.72K---5.85K----
Other non cash items -11.28%362.59K-30.51%408.69K-46.86%588.11K-67.01%1.11M--3.35M------------
Change In working capital -126.96%-381.56K-25.62%1.42M218.48%1.9M-182.52%-1.61M224.52%1.95M-356.69%-1.56M161.43%608.99K---991.33K
-Change in receivables -133.98%-321.42K18.76%945.8K259.05%796.4K-404.81%-500.72K111.07%164.28K-242.73%-1.48M379.95%1.04M---371.23K
-Change in inventory -153.71%-219.65K326.19%408.95K-568.14%-180.8K-2.74%38.62K-74.30%39.71K156.32%154.53K-171.41%-274.38K--384.22K
-Change in prepaid assets 241.98%172.53K-96.65%50.45K209.03%1.5M-566.89%-1.38M-640.34%-206.94K104.29%38.3K-272.94%-892.32K--515.96K
-Change in payables and accrued expense -747.65%-81.53K-102.91%-9.62K941.77%330.01K-102.08%-39.2K25,524.51%1.89M-101.06%-7.42K143.97%703.13K---1.6M
-Change in other current liabilities 151.15%38.06K79.38%-74.41K-206.90%-360.86K282.64%337.57K-279.14%-184.83K-113.36%-48.75K--365K----
-Change in other working capital -67.73%30.44K150.61%94.34K-198.48%-186.4K-125.22%-62.45K214.35%247.59K34.72%-216.52K-521.26%-331.69K--78.74K
Cash from discontinued investing activities
Operating cash flow -2,287.47%-1.93M-130.10%-80.76K120.38%268.29K-240.92%-1.32M290.58%934.25K-87.54%239.19K555.25%1.92M--293.04K
Investing cash flow
Cash flow from continuing investing activities 314.77%26.42K73.77%-12.3K99.19%-46.91K-5.62%-5.81M-800.97%-5.5M41.94%-610.09K-463.97%-1.05M-186.31K
Net PPE purchase and sale 90.01%-7.06K-13.11%-70.68K32.84%-62.49K77.12%-93.04K32.09%-406.66K41.85%-598.81K-474.68%-1.03M---179.18K
Net intangibles purchase and sale ------------------046.37%-11.28K-194.90%-21.03K---7.13K
Net investment purchase and sale ---------------8.85M--0--0--0----
Net other investing changes -42.64%33.49K274.69%58.38K-99.50%15.58K161.54%3.13M---5.09M------------
Cash from discontinued investing activities
Investing cash flow 314.77%26.42K73.77%-12.3K99.19%-46.91K-5.62%-5.81M-800.97%-5.5M41.94%-610.09K-463.97%-1.05M---186.31K
Financing cash flow
Cash flow from continuing financing activities -189.22%-2.62M84.41%2.94M-87.15%1.6M310.32%12.41M-66.55%3.02M2,977.66%9.04M-521.47%-314.22K-50.56K
Net issuance payments of debt -64.58%1.42M44.49%4M2,318.39%2.77M-101.42%-124.95K12,568.61%8.8M122.12%69.49K-521.47%-314.22K---50.56K
Net common stock issuance --0-29.54%2.19M--3.12M--0--0--6.49M--0----
Proceeds from stock option exercised by employees --0--0---30K--0--0------------
Net other financing activities -24.09%-4.04M23.55%-3.26M-134.00%-4.26M316.88%12.53M-332.85%-5.78M--2.48M--------
Cash from discontinued financing activities
Financing cash flow -189.22%-2.62M84.41%2.94M-87.15%1.6M310.32%12.41M-66.55%3.02M2,977.66%9.04M-521.47%-314.22K---50.56K
Net cash flow
Beginning cash position 11.55%17.37M16.55%15.57M83.33%13.36M-21.58%7.29M1,312.65%9.29M903.15%657.77K473.21%65.57K--11.44K
Current changes in cash -258.89%-4.53M56.81%2.85M-65.64%1.82M443.76%5.29M-117.74%-1.54M1,461.76%8.67M888.39%555.22K--56.17K
Effect of exchange rate changes 27.10%-765.23K-366.34%-1.05M-49.76%394.12K268.06%784.54K-1,160.84%-466.81K-200.13%-37.02K1,909.94%36.98K---2.04K
End cash Position -30.46%12.08M11.55%17.37M16.55%15.57M83.33%13.36M-21.58%7.29M1,312.65%9.29M903.15%657.77K--65.57K
Free cash flow -1,177.80%-1.94M-173.59%-151.44K114.60%205.8K-367.18%-1.41M242.25%527.59K-142.66%-370.89K714.58%869.44K--106.73K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified Opinion--
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%
Apple
AAPL
+1.27%

Unlock the Full List